Historical AI Consensus
This page preserves the research and market snapshot packaged for this batch. It is not updated with later prices or revised advisor outputs.
- Symbol
- SMR.NYSE
- Batch
- 7
- Published
- September 20, 2026
- AI Advisors
- 14
Historical AI Consensus Investment Thesis
NuScale Power (SMR) Stock Forecast and AI Rating
Forecast targets and rating
Published batch rating
NEUTRAL
Calculated from the frozen synthesized path using the same return, horizon, volatility and dividend rules as individual opinions.
1-Year
PARTIAL SELL$7.67
-7.2%5-Year
NEUTRAL$9.62
+16.3%Published batch insight
Certified Nuclear Design Faces Severe Dilution Amid Extended Utility Commercialization Timelines
Sharp divergence characterizes the outlook as an exclusive regulatory design certification contrasts with severe revenue drought and relentless share dilution. Substantial liquidity buffers solvency through 2028, but converting non-binding utility memoranda into bankable procurement remains the decisive hurdle for sustainable per-share value realization.
This analysis preserves the original published batch. Audit published forecasts in full transparency
Michael Burry (Vulture), Elon Musk (Visionary), Universal Investor (Polymath), Machiavelli (Insider), Warren Buffett (Value Purist), Sherlock Holmes (Whistleblower), Superintelligence (Anthropologist), Ray Dalio (Strategist), J.P. Morgan (Titan). Some archetypes run in multiple modes, resulting in 14 advisors total.
Gemini
Claude
ChatGPTFull published thesis
Executive Summary
If you invested $10,000 in NuScale Power at the forecast anchor (2026-09-18): $11,631 in five years versus $13,892 for S&P 500 benchmark.
20-quarter synthesized forecastPrice targets, quarterly returns and the reasoning behind each stepView tableClose table
Frozen forecast from 18 Sept 2026. Prices in USD; returns exclude dividends. Each quarter is compounded from the previous quarter.
Swipe the table horizontally to read every column.
| Quarter | Target (USD) | Quarter return | Total return | Forecast rationale |
|---|---|---|---|---|
| Q4 2026 | 7.58 | -8.40% | -8.40% | Tax-loss selling and active at-the-market equity issuance weigh on trading sentiment. Negligible third-quarter commercial revenue reinforces post-FEED hiatus concerns, while substantial balance-sheet liquidity establishes an initial valuation floor against further immediate downside. |
| Q1 2027 | 7.43 | -1.91% | -10.16% | Full-year filings confirm operating losses exceeding several hundred million dollars alongside ongoing share dilution. European project review delays temper narrative enthusiasm, prompting cautious consolidation as investors scrutinize customer financing timelines. |
| Q2 2027 | 7.60 | +2.30% | -8.09% | Supportive federal policy announcements and exploratory utility site evaluations spark a modest relief bounce. Speculative short covering temporarily lifts shares, though management continues utilizing equity facilities into technical strength. |
| Q3 2027 | 7.67 | +0.94% | -7.23% | Prolonged contract negotiations and utility reluctance to absorb first-of-a-kind cost liabilities induce renewed multiple compression. Persistent operating cash burn outpaces incoming engineering receipts, reminding markets of extended commercialization lead times. |
| Q4 2027 | 7.85 | +2.35% | -5.05% | Advancement in pre-construction engineering tranches and preliminary site authorizations generate selective optimism. The market rewards incremental project derisking, though disclosure of partner milestone obligations caps follow-through equity appreciation. |
| Q1 2028 | 7.68 | -2.13% | -7.08% | Annual financial reporting underscores an expanded share count resulting from systematic dilution. While treasury interest cushions operating burn, the absence of enforceable module fabrication backlogs keeps institutional valuation multiples restrained. |
| Q2 2028 | 7.88 | +2.51% | -4.74% | Initial heavy component forging activities at partner manufacturing facilities validate physical supply-chain readiness. Visible progress from blueprints to industrial hardware attracts long-term infrastructure allocators, supporting steady upward price discovery. |
| Q3 2028 | 7.77 | -1.33% | -6.01% | Intensifying regional power grid deficits and surging datacenter compute demand renew speculative appetite for modular baseload. Exploratory enterprise agreements boost sector multiples, partially offset by ongoing corporate equity issuance. |
| Q4 2028 | 7.96 | +2.36% | -3.79% | Macroeconomic liquidity constraints and year-end utility capital expenditure reviews prompt orderly consolidation. Investors balance durable technological exclusivity against the reality that first module commercial operation remains several years away. |
| Q1 2029 | 7.96 | +0.10% | -3.70% | Recognition of initial long-lead materials revenue and engineering services billings modestly lifts top-line figures. Demonstrable progress toward site civil works in primary reference projects restores investor confidence in commercial feasibility. |
| Q2 2029 | 8.27 | +3.82% | -0.03% | Prospective customer utility procurement cycles encounter minor scheduling deferrals under higher-for-longer capital financing costs. The stock digests recent gains as analysts adjust forward revenue recognition timelines to reflect delivery realities. |
| Q3 2029 | 8.40 | +1.64% | +1.62% | Formal execution of a commercial co-development framework with a major industrial or technology consumer triggers aggressive institutional re-rating. Validating private corporate off-take demand compresses the perceived technology adoption discount. |
| Q4 2029 | 8.46 | +0.67% | +2.30% | Module manufacturing authorizations unlock high-margin technology licensing milestones. Incoming customer deposits begin cushioning working capital requirements, providing tangible evidence of the asset-light licensing model's operational leverage. |
| Q1 2030 | 8.61 | +1.73% | +4.07% | Fabrication milestones at partner facilities validate standard modular assembly protocols. The narrative pivots from speculative development survival toward valuing contractually supported intellectual property, sustaining a constructive fundamental valuation floor. |
| Q2 2030 | 8.89 | +3.25% | +7.46% | Final regulatory safety certifications for uprated module configurations remove lingering technical compliance hurdles. Broadening utility pipeline visibility across North America and Europe spurs sustained institutional equity accumulation. |
| Q3 2030 | 8.82 | -0.74% | +6.66% | Inflationary pressure on specialized nuclear-grade alloys and specialized installation logistics prompts mild guidance revisions. Investors navigate transitory cost escalation, supported by indexed contract structures and established supply agreements. |
| Q4 2030 | 9.16 | +3.88% | +10.80% | Delivery of non-nuclear module structural assemblies to testing facilities demonstrates manufacturing schedule reliability. Tangible execution proof points reduce forward risk premiums, propelling the stock higher into annual closing sessions. |
| Q1 2031 | 9.26 | +1.06% | +11.98% | Reported financial results confirm expanding revenue from engineering oversight, software licensing, and hardware progress. Drastically reduced net operational cash burn validates business model maturation, prompting sell-side target upgrades. |
| Q2 2031 | 9.40 | +1.52% | +13.68% | Expanding international bilateral energy security pacts unlock follow-on module options across Central European industrial parks. Expanding addressable backlog visibility underwrites persistent multi-quarter price appreciation on commercial repeatability. |
| Q3 2031 | 9.62 | +2.32% | +16.31% | On-site module integration and cold functional testing confirm small modular reactor commercial viability. The equity achieves mature valuation parity as a specialized nuclear licensor, reflecting durable cash flows across an enlarged share base. |
NuScale commands an unmatched strategic asset: the only small modular reactor design certified by the Nuclear Regulatory Commission, providing an unreplicable regulatory head start. However, valuation models must distinguish between statutory design approval and commercial bankability. Following the completion of front-end engineering studies, quarterly revenue collapsed to negligible levels, leaving the enterprise with a trailing free cash flow burn of $777 million. Survival relies entirely on aggressive equity issuance, which expanded Class A shares to 410.4 million. The core investment tension centers on capital structure leakage: external commercialization partners capture direct project ownership and cash flows, while the company incurs significant milestone liabilities.
Key insights
- Regulatory certification provides essential option value, but customer conversion remains bottlenecked by $15,000 per kilowatt first-of-a-kind overnight capital hurdles.
- Relentless at-the-market equity dilution structurally transfers wealth from existing common shareholders to operating overhead, capping multiple expansion.
- Commercial off-take agreements trigger contractually mandated milestone payments to development partners, consuming treasury cash before module revenues materialize.
NuScale possesses a unique advantage as the only small modular nuclear reactor company with official approval from the Nuclear Regulatory Commission. This approval gives it a huge head start in powering future AI datacenters. However, the company currently generates almost no commercial revenue and burns hundreds of millions of dollars each year on overhead. To stay afloat, management continuously sells new shares of stock, which waters down current investors' ownership.
Key insights
- Regulatory approval proves the reactor design is safe, but utilities hesitate because initial plant construction costs remain high.
- Continuous sales of new shares create an ongoing supply overhang that limits per-share stock price gains.
- Complex partnership deals require paying large cash milestone fees to partners before receiving customer reactor payments.
Deep Dive
Prevailing market consensus treats NuScale as the premier pure-play proxy on the AI datacenter nuclear renaissance, assuming surging baseload demand guarantees multi-gigawatt utility orders. The crowd views non-binding memoranda as imminent contracted backlog, treating the $1.9 billion liquidity cushion as an unassailable floor while overlooking that near-zero revenue and persistent ATM dilution continuously erode per-share value.